Stay updated on Patisiran for hATTR Amyloidosis Clinical Trial
Sign up to get notified when there's something new on the Patisiran for hATTR Amyloidosis Clinical Trial page.

Latest updates to the Patisiran for hATTR Amyloidosis Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedPublications section now states that items are automatically filled from PubMed, and a UI revision note shows Revision: v3.3.2 (replacing v3.2.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange DetectedThe government funding notice banner was removed from the page, a general operational alert that did not affect the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check34 days agoChange DetectedNo significant changes to the study details are evident between the old and new screenshots; the page content and structure remain the same aside from minor UI adjustments. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check63 days agoChange DetectedVersion updated from v3.1.0 to v3.2.0 and an operational-status notice added; no other core content or pricing changes detected.SummaryDifference7%

- Check70 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.2%

- Check84 days agoChange DetectedRevision updated to v3.0.2 from v3.0.1; the Back to Top element was removed.SummaryDifference0.4%

Stay in the know with updates to Patisiran for hATTR Amyloidosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Patisiran for hATTR Amyloidosis Clinical Trial page.